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ABSTRACT  
Diathermy induced injury may affect detection of occult tubal lesions at risk 
reducing salpingo-oophorectomy (RRSO).  
 
Background  
Electro-surgery induced tubal thermal injury obscures cellular detail and hampers 
histo-morphological assessment for occult pathology. 
Objective 
To report on diathermy related thermal injuries to the fallopian tube observed at 
RRSO and explore its potential impact on the detection of occult tubal epithelial 
lesions. 
Design  
High-risk women from breast and/or ovarian cancer families attending a tertiary high-
risk familial gynaecological cancer clinic.  Retrospective case control analysis of 
high-risk women who underwent RRSO. Cases: All women detected to have occult 
lesions (tubal atypia/carcinoma in situ/cancer) between January-2005 and December-
2010. Controls: All women with normal tubal/ovarian histology between August-2006 
and December-2007 
Methods 
Two pathologists performed histopathological assessment for grade of thermal injury. 
Tubal diathermy injury rates were compared between cases and controls. Statistical 
analysis was undertaken using SPSS-18. The Mann-Whitney test compared age 
distributions, Chi-Square / Fisher’s tests the difference between proportions and 
Gamma test the difference in ordinal variables between the groups. 
Results 
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A novel tubal thermal index to describe the severity of injury is reported. Lack of 
fimbrial thermal injury is twice as likely (odds ratio 2.04, 95%CI 1.06,3.92) to be 
associated with detection of occult tubal pathology, whereas isthmic injury does not 
affect detection rate (p=0.744). The groups were comparable with respect to age at 
RRSO (p=0.531) and the presence of BRCA mutations (p=0.192). 
Conclusions  
This report highlights the potential impact of electrosurgical thermal injury on 
detection of occult tubal pathology following RRSO. It is important for surgeons to 
avoid thermal injury to the distal end of the tube.  
 
Key Words- 
Risk reducing, salpingo-oophorectomy, RRSO, diathermy, electrosurgery, thermal 
injury, tubal injury, occult pathology, fallopian tube, BRCA, fimbrial 
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Background  
Familial cancers are responsible for 5-10% of gynaecological cancers and mutations 
in the BRCA1 and BRCA2 genes account for most of the known hereditary risk for 
ovarian cancer (OC). These mutations have a low prevalence (1 in 300 to 1 in 800)1-4 
in the general population, but are associated with high penetrance. Meta-analyses 
report cumulative OC risks (till age 70 years) to be up to 40% for BRCA1 carriers, 
and up to 18% for BRCA2 carriers,5, 6 with even higher penetrances documented in 
carriers ascertained from high-risk families.7-10 The most effective management 
option for these women is risk reducing salpingo-oophorectomy (RRSO) (HR 0.21; 
CI 0.12, 0.39).11  
 
Occult invasive/in situ cancer has been documented in 4.7%12 (range 0 to 10%)13 of 
BRCA carriers and up to 3.1% of high-risk women with unknown mutation status 
(UMS) undergoing RRSO.14 Around  two-thirds of these lesions occur in the distal 
tube.15 Given the high incidence of occult cancer and potential implications for 
subsequent care, it is necessary to accurately identify these lesions. Use of a strict 
pathological protocol with 2-3 mm serial sectioning of the tube and ovary has been 
shown to increase the detection rate of occult cancers.12, 13, 16 Use of a SEEFIM 
(Sectioning and Extensively Examining the FIMbria) protocol has been reported to 
further improve detection of these lesions.17  
 
These efforts have led to the distal end of the tube, particularly the fimbriae, emerging 
as the site of origin of an increasing proportion of tubal/ovarian/ pelvic serous 
cancers.18-22 A putative precursor lesion (p53 signature) has been described in the 
fallopian tube and it is proposed that genotoxic injury is more likely to lead to 
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progression of these lesions to cancer in women at high risk for disease.23-25 There 
have also been reports of molecular and histological changes in tubal epithelium 
(particularly at the fimbrial end) which do not amount to carcinoma in situ (CIS),18, 20 
the clinical significance of which is yet to be established.  
 
RRSO is undertaken using a variety of different laparoscopic techniques with 
diathermy being one of the most commonly used techniques to secure pedicles and 
obtain surgical haemostasis. Electro-surgical diathermy induced thermal injury can 
obscure cellular detail and prevent complete morphological assessment. We report on 
the results of a pathological review of RRSO specimens undertaken to assess the 
frequency of diathermy associated thermal injury to the fallopian tube and explore its 
potential impact on the detection of occult tubal/ovarian pathology. In addition we 
propose a novel classification for grading severity of electrosurgical thermal injury in 
the fallopian tubes. 
 
Methods  
 
The primary recommendation for women at ‘high-risk’ for OC attending the 
multidisciplinary tertiary level UCLH familial gynaecological cancer clinic is RRSO 
once they have completed their family. Comprehensive advice on the advantages and 
disadvantages and the timing of RRSO is provided.26 Demographic, clinical and 
histopathological data are collected using a standardised proforma and stored in a 
bespoke familial clinic database.  
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Surgery involves removal of both tubes and ovaries (or all remaining adnexae in 
women who have undergone previous partial removal), peritoneal washings for 
cytological examination and endometrial sampling. All surgical procedures are 
undertaken or directly supervised by a consultant (attending surgeon) experienced in 
laparoscopic surgery. Bipolar thermocoagulation is used to achieve haemostasis in the 
ovarian and infundibular-pelvic pedicles, prior to excision with the use of 
laparoscopic scissors. Bipolar is set to 30-40 Watts. Specimens are processed by a 
dedicated senior pathologist (EB) with a special interest in familial gynaecological 
cancer. From 2005 onwards, a strict surgico-pathological protocol has been adopted. 
Serial transverse sectioning of the ovaries and the proximal, mid and distal fallopian 
tubes at 2mm intervals is undertaken, followed by perpendicular sectioning of the 
fimbrial end to maximise the surface area of the fimbrial plicae visualised. The entire 
specimen is embedded and microscopically examined. 
 
Histological assessment of dysplasia/atypia was based on epithelial and architectural 
changes, including degree of stratification, mitotic index, nuclear:cytoplasmic ratio, 
prominent nucleoli, hyperchromasia, chromatin clumping and loss of ciliated cells. 
Histological abnormalities not amounting to carcinoma insitu (CIS), but showing, 
some nuclear enlargement, hyperchromatic nuclei, incomplete replacement of the 
adjacent normal ciliated cells, and less than full thickness epithelial involvement with 
some preservation of epithelial polarity, were graded as mild- moderate epithelial 
atypia depending on the degree of abnormality. Occult lesion was defined as any case 
of tubal/ovarian cancer, carcinoma in situ or mild-moderate tubal atypia .   
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The familial clinic as well as the ‘CoPath’ pathology databases were searched for (a) 
all patients from breast and/or ovarian cancer families with occult lesions who 
underwent RRSO between Jan 2005 and December 2010 (‘cases’) and (b) all patients 
from breast and/or ovarian cancer families who underwent RRSO between August 
2006 and December 2007 (‘controls’). Cytology and histopathology reports and the 
slides were retrieved for all ‘cases’ and ‘controls’. A histological review of all the 
slides was undertaken by two pathologists (EB and AS) and consensus on findings 
achieved. 
 
All sections from the fallopian tubes were assessed for the presence/absence of heat 
artefact in the isthmic, ampullary and fimbrial regions of the tube. Electro-
surgery/diathermy induced thermal injury to the tube obscures cellular detail by 
blurring cellular outlines, causing elongation, hyperchromasia and smearing of 
nuclear DNA. Dependent on the extent of affected epithelial surface area of the 
section, the degree of tubal thermal injury was graded using a novel index, as 
follows– (a) Grade 0: No thermal artefact; (b) Grade 1 (mild): thermal artefact 
involving <20% epithelial surface area (Figure-1); (c) Grade 2 (moderate): thermal 
artefact involving 20-50% epithelial surface area (Figure-2); and (d) Grade 3 (severe): 
thermal artefact involving >50% epithelial surface area (Figure-3). When diathermy 
artefact was present in multiple sections the most severe grade of artefact identified 
was taken for the purpose of the analysis.  
 
Statistical analysis was undertaken using SPSS 18. The potential impact of diathermy 
induced thermal artefact on occult lesions was explored by undertaking a case-control 
analysis for frequency and grade of thermal artefact between these two groups. The 
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null hypothesis was defined as no difference in thermal injury between these two 
groups. For the purpose of this analysis the right and left adnexae were considered 
independent of each other. A per-tube analysis was undertaken to enable analysis of 
thermal injury data for each tube separately. Chi-Square test (n>30) and Fisher’s test 
(n<30) were used to calculate the difference between proportions. Odds Ratio was 
used to quantify the association of any differences in thermal injury between cases 
and controls. Gamma test was used to evaluate the difference in ordinal variables 
between the two groups. The Mann-Whitney non-parametric test was used to compare 
age distributions between groups after reviewing histograms. Two sided p values are 
reported for all statistical tests. 
 
Results 
 
A search of the familial clinic and CoPath databases for breast and/or OC families 
revealed (a) 37 cases and (b) 85 consecutive RRSO controls. Histological specimens 
were accessible for 34 ‘cases’ and 78 ‘controls’. Findings in the 34 cases were as 
follows: tubal/ovarian cancer in 7 patients, tubal CIS in 11 patients, and mild-
moderate tubal atypia in 16 patients.  
 
Characteristics of the ‘cases’ and ‘control’ groups are compared in Table-1. The two 
groups did not differ significantly with respect to age at surgery (p=0.531) or presence 
of BRCA1/2 mutations (p=0.192). Bilateral salpingo-oophorectomy was undertaken 
in 33 of 34 cases and in 75 of the 78 controls (Table-1). There were 67 tubes and 68 
ovaries in cases, and 154 tubes and 153 ovaries in the control groups respectively. The 
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different grades of tubal thermal injury found in the ‘cases’ and ‘control’ groups are 
given in Table-2.  
 
In both cases and controls, the highest rate of diathermy injury was in the isthmic 
region (Table 2) and in this region, there was no significant difference in the 
diathermy injury rates whether high-grade (p=0.546) or overall (p=0.744) between 
cases and controls (Table-2).  
 
However, comparing diathermy induced thermal artefact in the fimbrial region of the 
tube between cases and controls, there was a significant difference in the grades of 
injury (p=0.017) with 37% of controls having  some degree of diathermy induced 
thermal artefact present in the fimbrial region, compared to 22.4% of cases (odds ratio 
2.04, 95% CI 1.06, 3.92) (Table-2). Higher grades (Grade 2/Grade 3) of thermal 
injury were found to occur more commonly in the distal (ampullo-fimbrial) region of 
the tube in controls (29.2%) compared to cases (16.4%) (p= 0.044) (odds ratio 2.1 
95% CI 1.02, 4.32) (Table-1).  
 
Discussion 
 
To the best of our knowledge this is the first report high-lighting the potential impact 
of electrosurgical thermal injury on detection of occult tubal pathology following 
RRSO. Lack of fimbrial or Grade 2-3 distal tubal thermal injury is twice as likely to 
be associated with detection of occult tubal pathology. It is important for surgeons to 
avoid thermal injury to the distal end of the tube.  
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The two groups did not significantly differ with respect to age at surgery and presence 
of BRCA mutations (Table-1).  Of note, most of the tubal pathology was in the 
fimbrio-ampullary region, which is in keeping with reported literature and the fimbrial 
portion of the tube being the commonest site for occurrence of occult lesions in high-
risk women,23  
 
Use of our novel tubal thermal injury index that takes into account the extent of 
affected tubal surface area /severity and may serve as a useful histological reporting 
tool in women undergoing RRSO. Temperatures >42°C can cause cell membrane 
damage and protein denaturation leading to microscopic appearances of disruption of 
cellular outlines, detachment of epithelium, elongation, hyperchromasia, 
pseudostratification or loss of nuclei and homogenisation of connective tissue.27 This 
obscures cellular detail and hampers morphological assessment of the tubal 
epithelium. Given the potential impact on detection of small (few mm in size) 
intraepithelial/invasive carcinomas in RRSO specimens, quantification of thermal 
injury in histopathological reports seems warranted.   
 
It is possible that potentially missed occult invasive/in situ lesions may contribute to 
the residual risk of primary peritoneal cancer in these women.28 Long term follow up 
studies of women undergoing RRSO are ongoing to assess this risk. Routine reporting 
of grade of thermal injury in these women may provide information which can help 
shed further light on this issue.   
 
The similar high rates of isthmic tubal thermal injury observed in both groups are 
consistent with the surgical technique using diathermy. Most gynaecologists use 
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diathermy/ electrosurgery for haemostasis and securing pedicles at RRSO (including 
those at our institution). However, this can cause thermal damage beyond the point 
grossly visible to the naked eye, with the degree of lateral thermal spread dependent 
on the type of instrument used, the application time and power setting. Newer 
electrosurgical instruments: Harmonic ScalpelTM (Harmonic ACETM Ehthicon, USA) 
and LigaSureTM (Valleylab, Boulder, CO, USA) cause less collateral damage. but are 
only effective for securing vessels up to 5mm,29 and 7mm in size respectively. 
Amongst electrosurgical instruments, monopolar diathermy causes maximum lateral 
tissue damage (>1cm from point of application)30 with an area of coagulation necrosis 
twice as large as bipolar electrosurgery.31 It takes up to a minute for temperature at the 
tip of the instrument to reduce below 42°C.30 Bipolar, Harmonic ScalpelTM and 
LigaSureTM cause similar levels of thermal damage, with the latter producing the 
smallest rise in temperature.30 Thermal damage may be reduced by using shorter 
application times or midpoint interruptions with the same total duration of 
application,32 and use of non-electrosurgical techniques: intra/extra corporeal suturing 
or use of endoloops. However, suturing requires more advanced laparoscopic skills, 
and has cost and time implications. Cost is also a consideration with the use of 
advanced laparoscopic instruments such as Harmonic ScalpelTM and LigaSureTM. 
Additional artefacts which may obscure histological appearances include crush injury 
to the tube and in particular to the fimbrial end. It is important for all gynaecologists 
performing these procedures to be aware of these issues. 
 
The presence of occult invasive/in situ cancer at pathology has implications for future 
care and follow-up. These women may need referral to a gynaecological oncologist 
for assessment and further management. Routine peritoneal cytology is essential in 
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this population, as positive cytology in many situations determines the need for 
surgical staging and possible chemotherapy.33 As the UK national health service 
(NHS) provides restricted access to genetic testing for BRCA1/2 mutations, 
identifying occult lesions also means that individuals who have no live affected 
relatives with a relevant cancer diagnosis, are able to access genetic testing for 
themselves.26 A positive test permits predictive testing of other family members and 
may have implications for their own treatment (e.g. access to PARP inhibitors if 
chemotherapy is warranted). 
 
The limitations of our study include retrospective design and the lack of detailed data 
on co-morbidity such as endometriosis/adhesions that may have contributed to greater 
need for use of diathermy. 
 
Performing RRSO without subjecting the crucial fimbrial and ampullary regions of 
the fallopian tube to thermal damage or crush injury should be possible in the majority 
of cases. However, some degree of focal diathermy in the proximal isthmic portion of 
the fallopian tube may be unavoidable if electrosurgery is used to secure this pedicle. 
This should be acceptable as occult lesions are unlikely to occur in the proximal 
isthmic part of the tube.  Inadvertent injury should be minimised by avoiding  
monopolar diathermy, use of low power settings and short application times . Our 
experience and the literature indicate the need for an evidence based surgical protocol 
alongside a histopathological protocol in order to optimise both detection of occult 
pathology as wells as maximise benefit of ovarian cancer risk reduction. The surgico-
pathological protocol currently followed at our institution is provided in Table-3. 
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Conclusion 
Our findings for the first time high-light the potential impact of diathermy related 
thermal injury on detection of occult tubal pathology in women undergoing RRSO. 
We also propose a novel tubal thermal index for grading such injuries. Our data 
suggest that lack of fimbrial or Grade 2-3 distal tubal (fimbrio/ampullary) thermal 
injury is twice as likely to be associated with detection of occult tubal pathology. It is 
important that gynaecologists undertaking these procedures be made aware of these 
issues. A strict surgico-pathological protocol for RRSO should include both 
histopathological aspects (such as serial sectioning and peritoneal cytology), as well 
as appropriate surgical technique to optimise detection of occult pathology and 
maximise the benefits that identification of such lesions may confer on patients and 
their relatives.   
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Short Title 
Diathermy related tubal injury may affect detection of occult lesions at RRSO 
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TABLE AND FIGURE LEGENDS 
 
Table-1 
Characteristic of the two groups: 34 ‘occult cases’ and 78 ‘controls’ 
 
BSO- bilateral salpingo-oophorectomy, B/L- bilateral, C/L- contra-lateral, HBC – 
high-risk breast cancer only family, HBOC- high-risk breast and ovarian cancer 
family, HOC- high-risk ovarian cancer only family, IQR- inter quartile range, UMS- 
unknown mutation status, USO – unilateral salpingo-oophorectomy 
 
Table-2 
Grades of diathermy induced thermal injury in both groups  
Gr- grade, Mod- moderate, Sev- severe 
 
Table-3: UCLH Familial Cancer Clinic Surgico-histopathological Protocol 
 
 
Figure-1 
Histopathological section of the tube showing mild thermal injury changes 
 
The epithelium shows focal areas of disruption and detachment of tubal epithelium 
(arrows) with blurring of cell boundaries compared to normal epithelium (N) (x100)  
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Figure-2  
Histopathological section of the tube showing moderate thermal injury changes 
The changes of thermal injury are more extensive, encompassing 20-50% of the 
epithelial surface area. There is epithelial distortion with elongated hyperchromatic 
nuclei and indistinct cytoplasmic membranes. (x200) 
 
Figure-3 
Histopathological section of the tube showing severe thermal injury changes 
Widespread thermal injury entirely obscuring cellular detail, hampering 
histopathological assessment. Elongated and stratified appearance of nuclei with loss 
of cellular detail. The changes affect both the epithelium and subepithelial connective 
tissue and there is tissue disruption. (x200) 
 
 
